Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9178 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9048 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8816 |
High Similarity |
NPD7411 |
Suspended |
0.8774 |
High Similarity |
NPD7075 |
Discontinued |
0.8766 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8701 |
High Similarity |
NPD7819 |
Suspended |
0.8701 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8649 |
High Similarity |
NPD3750 |
Approved |
0.859 |
High Similarity |
NPD7768 |
Phase 2 |
0.8571 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD1510 |
Phase 2 |
0.8535 |
High Similarity |
NPD3749 |
Approved |
0.8516 |
High Similarity |
NPD6801 |
Discontinued |
0.8514 |
High Similarity |
NPD1549 |
Phase 2 |
0.8506 |
High Similarity |
NPD4380 |
Phase 2 |
0.8503 |
High Similarity |
NPD2796 |
Approved |
0.8462 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8447 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8389 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8355 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8355 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8311 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8311 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8302 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8299 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8293 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8276 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8231 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8231 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8228 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8212 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8194 |
Intermediate Similarity |
NPD920 |
Approved |
0.8194 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8176 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8176 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8171 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.817 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8165 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8153 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8151 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8133 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8065 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8065 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8065 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8065 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8056 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8056 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8039 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7986 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7976 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7964 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7964 |
Intermediate Similarity |
NPD7054 |
Approved |
0.795 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7947 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7922 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7917 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7902 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7901 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7895 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7895 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7892 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7857 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7847 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7843 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7824 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7808 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7808 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7805 |
Intermediate Similarity |
NPD919 |
Approved |
0.7798 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7765 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7755 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7727 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7719 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7682 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.764 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7614 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7603 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7597 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7548 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7548 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7548 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7547 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7542 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7542 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD2309 |
Approved |
0.75 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7457 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7456 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7451 |
Intermediate Similarity |
NPD943 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7434 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7434 |
Intermediate Similarity |
NPD411 |
Approved |
0.743 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7403 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7397 |
Intermediate Similarity |
NPD17 |
Approved |
0.7389 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7368 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD1164 |
Approved |
0.733 |
Intermediate Similarity |
NPD8313 |
Approved |
0.733 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD1247 |
Approved |
0.729 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7287 |
Intermediate Similarity |
NPD7584 |
Approved |
0.726 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7241 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7207 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD2354 |
Approved |
0.72 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7193 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7171 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.717 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.717 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7158 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7111 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.711 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7107 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7102 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7081 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7067 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7063 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7051 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7027
|
Intermediate Similarity |
NPD1894 |
Discontinued |